Why Is Dhanuka Agritech Share Price Falling? Key Reasons & Share Price Target

Fri Mar 27 2026

Dhanuka Agritech, one of India’s leading agrochemical formulation and marketing companies, has suffered one of the sharpest stock declines among its peers in FY26. From a 52-week high of Rs 1,975, the stock has crashed to around Rs 960-990 — a staggering fall of over 50%. For a company that posted 24.20% full-year profit growth in FY25, the speed and magnitude of this decline is alarming.

The Dhanuka Agritech share price falling narrative is driven by a toxic combination: weather-induced demand destruction, Q2 and Q3 FY26 financial deterioration, multiple GST demand notices, and a flat FY26 revenue guidance that stripped away the growth premium investors had assigned to this stock.

This article breaks down exactly why Dhanuka Agritech shares are falling, what the financials reveal, and what the share price target looks like for 2026 and beyond.

Table of Contents

About Dhanuka Agritech

Click Here – Get Free Investment Predictions

Incorporated in 1985 (as Dhanuka Pesticides Limited, renamed in 2007), Dhanuka Agritech is headquartered in Gurugram, Haryana. It is promoted by the Dhanuka Group of Industries and has established itself as a major formulator and marketer of crop protection products — insecticides (46% of Q2 FY26 revenue), fungicides (29%), herbicides (9%), and others (16%).

The company has over 300 product registrations, operates 3 manufacturing units with 39 warehouses, and distributes through 6,500 distributors and approximately 75,000-80,000 retailers reaching 10 million farmer touchpoints. It collaborates with 10 leading global agrochemical companies from Japan, the US, and Europe for in-licensing of novel products. With a market cap of approximately Rs 4,300-5,000 crore, it is an established mid-cap agri-input player.

Why Is Dhanuka Agritech Share Price Falling? Key Reasons

Tap to Access Best Research Pieces

1. Sharp Revenue and Profit Decline in Q2 and Q3 FY26

The most direct driver of the Dhanuka Agritech share price fall is the severe financial deterioration in FY26. In Q2 FY26 (September 2025), net profit crashed 20.04% YoY to Rs 93.97 crore and revenue declined 8.56% YoY to Rs 598.25 crore. Q3 FY26 (December 2025) was even worse — revenue dropped to Rs 409.9 crore from Rs 445.3 crore YoY, with profitability contracting sharply.

A company that delivered 24.20% full-year profit growth in FY25 was suddenly guiding for flat FY26 revenue — this guidance reset completely shattered investor expectations and triggered aggressive selling from momentum and growth investors who had priced in a premium multiple.

2. Adverse Weather Destroying Agrochemical Demand

Agrochemical demand in India is directly linked to monsoon patterns, crop acreage, and pest/disease pressure. FY26 saw adverse weather conditions — erratic monsoons, unseasonal rains, and drought in certain regions — that significantly reduced demand for pesticides and crop protection products. When farmers are uncertain about crop yields or face waterlogged fields, agrochemical usage falls sharply.

This weather-driven demand destruction is not unique to Dhanuka — it affects all agri-input companies — but Dhanuka’s portfolio concentration in insecticides (most weather-sensitive segment) made it more vulnerable than peers with more diversified product mixes.

3. Flat FY26 Revenue Guidance Shattering Growth Premium

Dhanuka’s management guided for flat FY26 revenue while focusing on ramping up the new Dahej plant. This guidance was a major negative surprise for the market. Dhanuka had been valued at 18-25x P/E on the assumption of consistent 12-15% annual revenue growth. Flat revenue guidance implied a valuation de-rating was inevitable — and the market delivered it aggressively.

By early 2026, the stock had corrected from Rs 1,975 to near its 52-week low of Rs 948 — a de-rating that took the P/E from 22-25x down to approximately 16-17x, reflecting the reset in growth expectations.

4. GST Demand Notices Creating Legal Overhang

Dhanuka Agritech received multiple GST demand notices during FY26. A Rs 121.3 crore GST demand from CGST Ahmedabad (which the company deems unjust and plans to appeal) and a Rs 1.64 crore demand from Rajasthan’s GST department added a legal and financial uncertainty overhang. Additionally, a Rs 14.96 crore tax demand for FY 2015-18 from Haryana Entry Tax and a Rs 83.71 lakh assessment order (March 2026) all compound the regulatory risk perception.

While the company has contested each demand and management believes these are non-maintainable, the aggregate value — especially the Rs 121.3 crore CGST demand — represents a material contingent liability relative to the company’s quarterly profits. Markets dislike regulatory uncertainty, and these notices kept risk-averse investors away.

5. New Dahej Plant Ramp-Up Slower Than Expected

Dhanuka’s strategic pivot involves a new manufacturing plant at Dahej (Gujarat), which represents a significant capital investment and shift from a pure formulation/marketing model toward more backward-integrated manufacturing. However, plant ramp-ups are rarely smooth — management targeted only 80% capacity utilisation by FY27, implying the plant will be a drag rather than a contributor through most of FY26.

Investors who expected the Dahej plant to immediately add to revenues and margins were disappointed by the timeline. The plant represents long-term strategic value but near-term earnings dilution — a classic capex-phase trap that triggered selling from near-term-focused investors.

6. Chinese Agrochemical Dumping and Import Competition

Indian agrochemical markets have faced increasing competition from Chinese technical grade material imports, which undercut domestic pricing. For a company like Dhanuka that relies on imported active ingredients (AI) from global partners, rising import costs combined with pricing pressure from cheap Chinese formulations create a margin squeeze from both sides.

The regulatory landscape for biostimulants and new product categories is also evolving, creating near-term uncertainty about product launches and revenue timing — an important factor given Dhanuka’s strategy of launching in-licensed novel products to drive growth.

Dhanuka Agritech Latest News That Impacted the Stock

October 31, 2025: Q2 FY26 results investor call — revenue -8.56% YoY, net profit -20.04% YoY; flat FY26 guidance issued; stock reaction strongly negative.
November 2025: Dhanuka Agritech receives Rs 121.3 crore GST demand from CGST Ahmedabad — company plans appeal.
December 2025: Rs 1.64 crore GST demand from Rajasthan GST Department; company classifies as non-maintainable.
December 2025: Rs 14.96 crore tax demand for FY 2015-18 from Haryana Entry Tax; company disputes and files legal action.
February 5, 2026: Q3 FY26 results — revenue drops to Rs 409.9 crore from Rs 445.3 crore YoY; profitability contracts sharply; stock near 52-week low.
March 9-10, 2026: Rs 83.71 lakh assessment order (AY 2018-19) received; writ petition filed.

Shareholder meeting approves new Independent Director.

March 2026: Stock near 52-week low of Rs 948; mutual fund holding at 15.67%; market cap approximately Rs 4,300 crore.

Financial Performance Analysis

The contrast between FY25’s strong 24.20% profit growth and FY26’s sharp deterioration captures the cyclical and weather-sensitive nature of the agrochemical business. Dhanuka’s fundamentals remain intact (debt-free, strong product portfolio), but the near-term financial picture is challenging.

Metric	Q2 FY26 (Sep 2025)	Q2 FY25 (Sep 2024)	YoY Change
Revenue (Rs Cr)	598.25	654.28	-8.56%
OPM %	~18.86%	24.39%	-553 bps
PBDT (Rs Cr)	142.24	169.33	-16.0%
PBT (Rs Cr)	125.98	156.66	-19.6%
Net Profit (Rs Cr)	93.97	117.52	-20.04%

The Q2 FY26 data tells a clear story: all key financial metrics are declining. Revenue, operating profit, and net profit are all heading lower, with OPM compressing by 553 basis points. For a company in the consumer/agri-input space, this level of margin compression reflects both demand destruction and pricing pressure simultaneously.

Positively, Dhanuka is almost debt-free and has a strong balance sheet that can weather the near-term storm. Annual FY25 performance remains solid — net profit of Rs 296.96 crore on revenues of Rs 2,035 crore — providing a base for recovery once agrochemical demand normalises. Track live metrics on Univest Screener at univest.in/screeners.

Technical Signals: What the Charts Are Saying

Dhanuka Agritech is in a confirmed technical downtrend, trading 51% below its 52-week high of Rs 1,975 at around Rs 960-990. The 52-week low of Rs 948-950 represents the near-term support zone. Any bounce from here faces resistance at Rs 1,100-1,200 (previous support turned resistance band).

The stock has been making lower highs and lower lows consistently since the FY26 guidance reset. A sustained move above Rs 1,200 with volume would be required to signal a genuine trend reversal. The mutual fund shareholding of 15.67% suggests there is still institutional interest, but the near-term technical picture remains bearish. Download the Univest iOS App or Univest Android App for live price alerts.

Market Sentiment and Institutional Positioning

Dhanuka’s promoters (the Dhanuka Group, promoted by R.G. Agarwal family) typically hold a significant majority stake. Mutual fund holding stands at 15.67% — moderate for a mid-cap agrochemical company. The recent appointment of a new Independent Director (Mahesh Parshuram Sonawane, December 2025) and the postal ballot approval of Sanjiv Goel as Independent Director signal ongoing governance improvement.

However, the combination of flat guidance, multiple regulatory demands, and weather-driven demand uncertainty has kept institutional buying muted. FII holding in mid-cap agrochemical stocks has been subdued in FY26, and Dhanuka has not been an exception.

Future Outlook: Can Dhanuka Agritech Recover?

The recovery thesis for Dhanuka rests on three pillars: normalisation of agrochemical demand in the upcoming kharif season (June-October 2026), Dahej plant reaching meaningful utilisation levels by FY27, and new product launches (management plans new launches to drive growth).

India’s long-term agrochemical story remains very strong — low pesticide usage intensity versus global peers, growing farmer awareness of crop protection, government support for agricultural productivity, and Dhanuka’s unique position with in-licensed novel molecules from global partners all provide structural tailwinds.

The Q4 FY25 quarter had shown a 27.92% net profit jump — demonstrating that when conditions normalise, the company can recover sharply. Management has guided for positive outlook for the upcoming kharif season, and the rabi season stabilisation signal from Q4 FY25 suggests the business model is fundamentally sound.

The contrarian view: the agrochemical sector faces structural challenges — Chinese AI dumping, farmer distress limiting spending, and climate change making monsoon patterns more erratic. If FY27 also sees weather disruptions, the flat-to-declining revenue trend could persist, and the stock may not recover to anywhere near Rs 1,975 for an extended period.

Dhanuka Agritech Share Price Target

Click Here – Get Free Investment Predictions

1. Short-Term Share Price Target (3-6 Months)

Near-term estimates suggest a range of Rs 1,000-1,100 (conservative) to Rs 1,200-1,300 (bull case), contingent on kharif 2026 demand signals being positive and the Dahej plant showing meaningful revenue contribution.

2. 12-Month Share Price Target

Based on normalised FY27 earnings estimates and historical valuation multiples of 18-22x P/E, analysts suggest a 12-month target range of Rs 1,200-1,500 — representing 25-55% potential upside from the 52-week low zone. This assumes demand normalisation and flat-to-modest revenue recovery.

3. Long-Term Share Price Target (2027-2028)

On a 2-year view, if Dahej plant reaches 80%+ utilisation, new product launches drive growth, and weather conditions normalise, Dhanuka could potentially approach Rs 1,500-1,800 levels. The path back to Rs 1,975 (52-week high) would require a full normalisation cycle plus growth premium restoration. Explore Univest Screener (univest.in/screeners) for detailed agrochemical sector peer analysis.

Conclusion

Dhanuka Agritech share price has crashed over 50% from its 52-week high due to a weather-induced demand destruction in agrochemicals, sharp Q2 and Q3 FY26 financial deterioration, flat FY26 revenue guidance, multiple GST demand notices, and slow Dahej plant ramp-up. Short-term recovery targets are Rs 1,000-1,200, with a 12-month target range of Rs 1,200-1,500 for investors who believe in the long-term India agrochemical story. The recovery is contingent on kharif 2026 demand normalisation and management execution.

*This article is for informational purposes only. Please conduct your own research and consult a SEBI-registered financial advisor before making any investment decisions.*

FAQs

Q1. Why is Dhanuka Agritech share price falling?

Dhanuka Agritech shares are falling due to a 20% YoY net profit crash in Q2 FY26, weather-induced agrochemical demand destruction (erratic monsoons), flat FY26 revenue guidance that shattered the growth premium, multiple GST demand notices (including Rs 121.3 crore from CGST Ahmedabad), and slower-than-expected Dahej plant ramp-up.

Q2. What is the Dhanuka Agritech share price target for 2026?

Analyst estimates suggest a 12-month target range of Rs 1,200-1,500 for Dhanuka Agritech. Short-term targets are Rs 1,000-1,200. A 2-year view could see the stock approach Rs 1,500-1,800 if demand normalises, Dahej plant ramps up, and new products are launched successfully.

Q3. Is Dhanuka Agritech a good buy at current levels?

Dhanuka is nearly debt-free, has strong product registrations (300+), and benefits from India’s structural agrochemical demand growth story. However, near-term earnings visibility is low and multiple regulatory overhang exists. This is not a buy/sell recommendation — conduct your own research and consult a SEBI-registered financial advisor.

Q4. What is the latest news on Dhanuka Agritech?

Recent news includes: Rs 121.3 crore GST demand from CGST Ahmedabad (contested), Rs 83.71 lakh assessment order (March 2026), Q3 FY26 revenue declining to Rs 409.9 crore, approval of new Independent Director at shareholder meeting (March 2026), and management’s positive outlook for kharif 2026 season.

Q5. What is the market cap and P/E of Dhanuka Agritech?

As of March 2026, Dhanuka Agritech has a market cap of approximately Rs 4,300-4,900 crore. The P/E is around 16-17x trailing earnings (significant de-rating from the 22-25x it commanded at the 52-week high). The P/B is approximately 3.5-3.8x. The company declared a dividend of Rs 2 per share in FY25.

Q6. Who are the promoters of Dhanuka Agritech?

Dhanuka Agritech is promoted by the Dhanuka Group of Industries, with R.G. Agarwal as the chairman. The company is headquartered in Gurugram, Haryana. Promoter holding is significant (details vary by quarter). Mutual fund holding stood at 15.67% as of March 2026.

Q7. What are the recovery triggers for Dhanuka Agritech?

Key catalysts: (1) Kharif 2026 season demand normalisation, (2) Dahej plant reaching 80% utilisation by FY27, (3) resolution or dismissal of GST demand notices, (4) new in-licensed product launches driving revenue, (5) Chinese AI import duty relief, and (6) biostimulant regulatory clarity enabling new product category growth.

Q8. What are the key risks for Dhanuka Agritech?

Major risks include: continued weather disruption impacting agrochemical demand in kharif 2026, adverse outcomes on the Rs 121.3 crore GST demand, slower Dahej plant ramp-up, intensifying Chinese agrochemical import competition, farmer income stress reducing crop protection spending, and broader agri-input sector de-rating.